Cargando…
Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides
Human topoisomerase II (topo II) is the cellular target for a number of widely used antitumor agents, such as etoposide (VP16). These agents ‘poison’ the enzyme and induce it to generate DNA breaks that are lethal to the cell. Topo II-targeted drugs show a limited sequence preference, triggering dou...
Autores principales: | Duca, Maria, Guianvarc'h, Dominique, Oussedik, Kahina, Halby, Ludovic, Garbesi, Anna, Dauzonne, Daniel, Monneret, Claude, Osheroff, Neil, Giovannangeli, Carine, Arimondo, Paola B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447649/ https://www.ncbi.nlm.nih.gov/pubmed/16598074 http://dx.doi.org/10.1093/nar/gkl126 |
Ejemplares similares
-
The triple helix: 50 years later, the outcome
por: Duca, Maria, et al.
Publicado: (2008) -
Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment
por: Brunet, Erika, et al.
Publicado: (2006) -
Sequence-specific DNA cleavage mediated by bipyridine polyamide conjugates
por: Simon, Philippe, et al.
Publicado: (2008) -
Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences
por: Infante Lara, Lorena, et al.
Publicado: (2018) -
The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing
por: Deweese, Joseph E., et al.
Publicado: (2009)